Human Epidermal Melanocytes-dark (HEM)

Cat.No.: CSC-7787W

Species: Human

Source: Epidermis

Cell Type: Melanocyte

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-7787W
Description
The melanocyte is a neural crest-derived cell that localizes in humans to several organs including the epidermis, eye, inner ear and leptomeninges. The failure of melanocytes to migrate to these locations explains the association of congenital white spotting of the skin (piebaldism) with heterochromia (the juxtaposition of different colors) in the iris as well as congenital deafness in Waardenburg syndrome. In the skin, melanocytes synthesize and transfer melanin pigments to surrounding keratinocytes, leading to skin pigmentation and protection against solar exposure. Recent progress in basic cell-culture technology, along with an improved understanding of culture requirements, has led to the success in culturing of this special cell type in pure population and the discovery of a novel melanocyte-specific gene, msg1, which encodes a nuclear protein and is associated with pigmentation.HEM-d from Bioarray Research Laboratories are isolated from neonate human epidermis. HEM-d are cryopreserved on passage one culture and delivered frozen. Each vial contains >5 x 105 cells in 1 ml volume. HEM-d are characterized by immunofluorescent method with antibodies to fibronectin and NGF-receptor (p75). HEM-d are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi. HEM-d are guaranteed to further expand for 15 population doublings in the condition provided by Bioarray Research Laboratories.
Species
Human
Source
Epidermis
Cell Type
Melanocyte
Disease
Normal
Storage and Shipping
Directly and immediately transfer cells from dry ice to liquid nitrogen upon receiving and keep the cells in liquid nitrogen until cell culture needed for experiments.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

The human epidermal melanocytes-dark (HEM-d) cell line is a highly pigmented, dark melanin-rich melanocyte cell line isolated from human epidermal tissue. These cells exhibit the typical morphology of melanocytes, notably possessing dendritic extensions that facilitate effective communication and interaction with surrounding cells. Primarily located in the basal layer of the epidermis, HEM-d cells engage in close interactions with keratinocytes, transferring melanin granules through these dendritic processes to confer ultraviolet (UV) protection to the skin. In addition, HEM-d cells are integral to regulating cutaneous immune response and antioxidant processes, which are vital for maintaining skin health.

The HEM-d cell line is used in a variety of research applications to study dermatological science, the treatment of skin diseases, and the production and distribution of melanin.  Scientists use these cells for in vitro studies designed to explore molecular controls of melanin production and how environmental conditions (UV exposure, chemicals) impact melanin synthesis and distribution. Furthermore, HEM-d cells are used to measure how pharmaceutical agents affect melanocyte proliferation, differentiation, pigment production and survival. The research presents new findings and potential strategies for skin diseases.

Darkly human primary epidermal melanocytes.Fig. 1. Human primary epidermal melanocytes from darkly-pigmented (Goenka S, and Simon SR, 2021).

The Influence of Fluoroquinolones and UVA Radiation on Melanin Content in Melanocytes

Fluoroquinolones (FQs) are antibiotics that have a broad spectrum - they're effective against many infections, but also cause phototoxicity, including skin hyperpigmentation, when they attach to melanin. Depending on their chemical structure, FQs vary in phototoxicity, with lomefloxacin and moxifloxacin the most and least phototoxic variants, respectively. Kowalska's team tested the phototoxicity of lomefloxacin and moxifloxacin on melanogenesis in normal human epidermal (dark-pigmented) melanocytes after UVA treatment.

These indicated that 0.05 mM and 0.5 mM omefloxacin decreased melanin by approximately 7% and 14%, respectively (Fig. 1A), and 1.0 mM moxifloxacin reduced melanin by 34 per cent (Fig. 1B). Only UVA exposure heightened melanin by 8 per cent. UVA increased melanin levels (13%-32%) over control when combined with lomefloxacin at all concentrations. In particular, lomefloxacin, both at 0.05 and 0.5 mM, showed greater melanin levels under UVA than cells exposed to untreated irradiation. For moxifloxacin, the 0.01 mM UVA treatment induced an 11% increase in melanin. However, other tested moxifloxacin concentrations did not elevate melanin compared to untreated, irradiated cells (Fig. 1B). Findings reveal that both drugs inhibit melanogenesis, with lomefloxacin enhancing UVA-induced effects differently.

Fluoroquinolones reduce melanin levels in melanocytes independently. Lomefloxacin enhances UVA radiation's effect on melanin levels.Fig. 1. Fluoroquinolones alone decrease melanin content in melanocytes. Lomefloxacin potentiates the impact of UVA radiation on melanin content (Kowalska J, Banach K, et al., 2021).

Effects of Xanthohumol in HEM-DP cells

Xanthohumol (XH) is a hops flavonoid that depigments mouse melanoma cells, but no one knows how it will affect human melanocytes. Flavonoids were shown to modulate the production and transport of human melanin – it's important to find out how XH could be used in human melanocyte cells.

In order to determine if XH is anti-melanogenic in normal melanocytes, Goenka et al. assessed cell death, melanin production, and tyrosinase activity following XH treatment in darkly-pigmented (HEM) human primary epidermal melanocytes. They discovered that XH was cytotoxic at 10 M, which cut down viability by 65.97%; concentrations less than 10 M were non-toxic and were used as control. XH inhibited tyrosinase activity by 36.57% at 2.5 μM and 47.61% at 5 μM (Fig. 2B) but did not affect melanin synthesis (Fig. 2C). As XH did not affect melanin biosynthesis in HEM-DP cells, they then tested whether XH could suppress melanosome export (by measuring the density of the cell). XH changed the cell structure at 2.5 and 5 M, resulting in fewer branched dendrites than the control (Fig. 3A). The number of dendrites decreased by 25.22 and 27.78%, respectively (Fig. 3B). Longitudinal dendrite length dropped by 15.09% and 20.5% at 2.5 M, respectively (Fig. 3C). Multi-dendritic cell counts dropped 39% and 48%, respectively, at 2.5 and 5 M (Fig. 3D). Taken together, the results demonstrate that XH inhibits melanosome export without affecting melanin synthesis.

Evaluating the viability, melanin production, and tyrosinase activity of HEM-DP cells under varying XH concentrations.Fig. 2. Viability, melanin synthesis and cellular tyrosinase activity of HEM-DP cells in the presence of different concentrations of XH (Goenka S, and Simon SR, 2021).

Analysis of HEM-DP cell structure and dendricity assessment.Fig. 3. HEM-DP cell morphology and dendricity measurement (Goenka S, and Simon SR, 2021).

Ask a Question

Write your own review

For research use only. Not for any other purpose.